Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice
- 1 November 2002
- Vol. 132 (5) , 857-865
- https://doi.org/10.1067/msy.2002.127680
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Microencapsulated cell-mediated treatment of inoperable pancreatic carcinomaThe Lancet, 2001
- Novel Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Tumor Vaccine for Pancreatic Cancer: A Phase I Trial of Safety and Immune ActivationJournal of Clinical Oncology, 2001
- Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238Proceedings of the National Academy of Sciences, 2000
- Current Approaches and Future Strategies for Pancreatic CarcinomaInvestigational New Drugs, 2000
- Current chemotherapeutic possibilities in pancreaticobiliary cancerAnnals of Oncology, 1999
- Pancreaticobiliary cancer: The future aspects of medical oncologyAnnals of Oncology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Gene Therapy and Pancreatic CancerSurgical Oncology Clinics of North America, 1998
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971